Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 11.77
(-0.17%)
CNY 11.77
(-0.17%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 15.08 Million CNY | -74.5% |
| 2022 | 59.15 Million CNY | -60.83% |
| 2021 | 151.02 Million CNY | -14.44% |
| 2020 | 176.51 Million CNY | 124.7% |
| 2019 | 78.55 Million CNY | -3.6% |
| 2018 | 81.49 Million CNY | -21.17% |
| 2017 | 103.37 Million CNY | 89.63% |
| 2016 | 54.51 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -585.01 Thousand CNY | 69.31% |
| 2024 Q3 | -1.22 Million CNY | 85.78% |
| 2024 Q2 | -8.6 Million CNY | -1371.5% |
| 2023 Q1 | 16.61 Million CNY | -42.14% |
| 2023 FY | 15.08 Million CNY | -74.5% |
| 2023 Q4 | -1.9 Million CNY | 27.46% |
| 2023 Q3 | -2.62 Million CNY | -187.66% |
| 2023 Q2 | 2.99 Million CNY | -81.96% |
| 2022 Q2 | 5.56 Million CNY | 15.99% |
| 2022 FY | 59.15 Million CNY | -60.83% |
| 2022 Q1 | 4.79 Million CNY | -62.81% |
| 2022 Q3 | 20.06 Million CNY | 260.52% |
| 2022 Q4 | 28.72 Million CNY | 43.13% |
| 2021 Q4 | 12.9 Million CNY | -35.23% |
| 2021 FY | 151.02 Million CNY | -14.44% |
| 2021 Q3 | 19.92 Million CNY | -55.29% |
| 2021 Q1 | 73.63 Million CNY | 16.78% |
| 2021 Q2 | 44.56 Million CNY | -39.47% |
| 2020 FY | 176.51 Million CNY | 124.7% |
| 2020 Q4 | 63.05 Million CNY | 20.17% |
| 2020 Q3 | 52.46 Million CNY | 66.57% |
| 2020 Q2 | 31.49 Million CNY | 6.78% |
| 2020 Q1 | 29.49 Million CNY | -22.53% |
| 2019 Q3 | 10.5 Million CNY | 0.0% |
| 2019 Q4 | 38.07 Million CNY | 262.37% |
| 2019 FY | 78.55 Million CNY | -3.6% |
| 2018 FY | 81.49 Million CNY | -21.17% |
| 2017 FY | 103.37 Million CNY | 89.63% |
| 2016 FY | 54.51 Million CNY | 0.0% |